We are live on ! Find out more
FLGT icon

Fulgent Genetics

14 hedge funds and large institutions have $8.85M invested in Fulgent Genetics in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

17% more capital invested

Capital invested by funds: $7.55M → $8.85M (+$1.3M)

0.3% more ownership

Funds ownership: 6.81%7.11% (+0.3%)

13% less funds holding

Funds holding: 1614 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
7
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

FLGT Hedge Fund Activity: Q2 2019 in Review

14 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2019, worth a combined $8.85M — up 17% from $7.55M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of FLGT and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 7 added.

The largest buyer was Essex Investment Management, adding an estimated $393K. The largest seller was Brown Advisory, exiting entirely with an estimated $86K sold.

  • 14 institutional investors held Fulgent Genetics (FLGT) as of Q2 2019, down from 16 in Q1 2019.
  • Funds reported $8.85M of Fulgent Genetics stock for Q2 2019, up 17% quarter-over-quarter.
  • 0 funds opened new Fulgent Genetics positions in Q2 2019 and 2 closed out, a net change of -2 holders.
  • The largest Fulgent Genetics buyer in Q2 2019 was Essex Investment Management, an estimated $393K added.
  • The largest Fulgent Genetics seller in Q2 2019 was Brown Advisory, an estimated $86K sold.

Based on aggregated 13F filings for Q2 2019.